Story perspectives

McDonald's Adapts Menu Amid Rising Weight-Loss Drug Use

2/18/2026

Summary

Story summary

McDonald's is testing new protein-rich menu items in response to rising GLP-1 weight-loss drug use among Americans.
Chief Executive Officer Chris Kempczinski said about 12.4% of U.S. adults now use these medications, influencing eating habits.
Other chains, including Olive Garden and Chipotle, are also adapting their menus to lighter options.
The trend reflects a broader shift in the fast-food industry toward nutritional density and customization to meet health-conscious consumers.

1 of 1

Story summary

McDonald's is testing new protein-rich menu items in response to rising GLP-1 weight-loss drug use among Americans.
Chief Executive Officer Chris Kempczinski said about 12.4% of U.S. adults now use these medications, influencing eating habits.
Other chains, including Olive Garden and Chipotle, are also adapting their menus to lighter options.
The trend reflects a broader shift in the fast-food industry toward nutritional density and customization to meet health-conscious consumers.